181 related articles for article (PubMed ID: 25011545)
1. Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway.
Catteau X; Simon P; Noël JC
BMC Cancer; 2014 Jul; 14():499. PubMed ID: 25011545
[TBL] [Abstract][Full Text] [Related]
2. Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.
Catteau X; Simon P; Vanhaeverbeek M; Noël JC
PLoS One; 2013; 8(3):e57773. PubMed ID: 23469238
[TBL] [Abstract][Full Text] [Related]
3. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
5. Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.
Yamashita M; Ogawa T; Zhang X; Hanamura N; Kashikura Y; Takamura M; Yoneda M; Shiraishi T
Breast Cancer; 2012 Apr; 19(2):170-6. PubMed ID: 20978953
[TBL] [Abstract][Full Text] [Related]
6. Myofibroblastic reaction is a common event in metastatic disease of breast carcinoma: a descriptive study.
Catteau X; Simon P; Noël JC
Diagn Pathol; 2014 Oct; 9():196. PubMed ID: 25339428
[TBL] [Abstract][Full Text] [Related]
7. Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast.
Barth PJ; Moll R; Ramaswamy A
Virchows Arch; 2005 May; 446(5):532-6. PubMed ID: 15838642
[TBL] [Abstract][Full Text] [Related]
8. The Significance of the Stromal Response in Breast Cancer: An Immunohistochemical Study of Myofibroblasts in Primary and Metastatic Breast Cancer.
Roozdar A; Hayes MM; Pourseyedei B; Zeinalinejad H; Shamsi Meymandi M; Dabiri B; Dabiri S
Arch Iran Med; 2018 May; 21(5):185-190. PubMed ID: 29738261
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD34, alpha-smooth muscle actin and transforming growth factor-beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the cervix.
Li Q; Huang W; Zhou X
J Int Med Res; 2009; 37(2):446-54. PubMed ID: 19383239
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breast.
Westhoff CC; Jank P; Jacke CO; Albert US; Ebrahimsade S; Barth PJ; Moll R
Virchows Arch; 2020 Nov; 477(5):717-724. PubMed ID: 32435886
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast.
Yazhou C; Wenlv S; Weidong Z; Licun W
Tumour Biol; 2004; 25(5-6):290-5. PubMed ID: 15627894
[TBL] [Abstract][Full Text] [Related]
12. c-Jun N terminal kinase modulates NOX-4 derived ROS production and myofibroblasts differentiation in human breast stromal cells.
Tobar N; Toyos M; Urra C; Méndez N; Arancibia R; Smith PC; Martínez J
BMC Cancer; 2014 Aug; 14():640. PubMed ID: 25175743
[TBL] [Abstract][Full Text] [Related]
13. Distribution of myofibroblast cells and microvessels around invasive ductal carcinoma of the breast and comparing with the adjacent range of their normal-to-DCIS zones.
Dabiri S; Talebi A; Shahryari J; Meymandi MS; Safizadeh H
Arch Iran Med; 2013 Feb; 16(2):93-9. PubMed ID: 23360631
[TBL] [Abstract][Full Text] [Related]
14. [Expression of TGF-beta1 and the mechanism of invasiveness and metastasis induced by TGF-beta1 in breast cancer].
Bao J; Wu ZS; Qi Y; Wu Q; Yang F
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):679-82. PubMed ID: 20021864
[TBL] [Abstract][Full Text] [Related]
15. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
Kojc N; Zidar N; Vodopivec B; Gale N
Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
[TBL] [Abstract][Full Text] [Related]
17. CD34(+) fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri.
Barth PJ; Ramaswamy A; Moll R
Virchows Arch; 2002 Dec; 441(6):564-8. PubMed ID: 12461613
[TBL] [Abstract][Full Text] [Related]
18. Quantification of stromal reaction in breast carcinoma and its correlation with tumor grade and free progression survival.
Catteau X; Simon P; Jondet M; Vanhaeverbeek M; Noël JC
PLoS One; 2019; 14(3):e0210263. PubMed ID: 30897102
[TBL] [Abstract][Full Text] [Related]
19. CD34(low) and SMA(high) represent stromal signature in uterine cervical cancer and are markers for peritumoral stromal remodeling.
Horn LC; Schreiter C; Canzler A; Leonhardt K; Einenkel J; Hentschel B
Ann Diagn Pathol; 2013 Dec; 17(6):531-5. PubMed ID: 24183311
[TBL] [Abstract][Full Text] [Related]
20. CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers.
Mezawa Y; Daigo Y; Takano A; Miyagi Y; Yokose T; Yamashita T; Morimoto C; Hino O; Orimo A
Cancer Med; 2019 Jul; 8(8):3936-3948. PubMed ID: 31140748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]